BenQ Medical Technology Corporation (TPEX:4116)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
44.20
+1.35 (3.15%)
Oct 30, 2026, 1:30 PM CST

BenQ Medical Technology Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5,4455,2544,7674,5434,3771,465
Revenue Growth
6.83%10.21%4.94%3.80%198.82%4.55%
Gross Profit
1,7681,6901,4481,3441,247512.28
Operating Income
340.72342.42333.02365.44350.2646.46
Net Income
117.6978.17104.83114.58180.2428.84
Earnings Per Share
2.631.752.342.564.020.65
EPS Growth
38.32%-25.21%-8.59%-36.32%521.20%-53.44%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Medical Services
4,5914,3873,7863,5323,352481.86
Adjustment and Elimination
-73.06-74.87-56.79-20.52-65.59-35.9
R&D and Manufacturing Department
927.1941.421,0391,0321,0901,019
Total
5,4455,2544,7674,5434,3771,465

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
958.861,1881,1461,1541,167419.19
Total Debt
1,9971,9891,9061,5721,117491.75
Net Cash (Debt)
-1,038-800.37-760.13-418.1550.19-72.55
Net Cash Growth
------
Net Cash Per Share
-23.15-17.87-16.96-9.331.12-1.62

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
404.12358.75222.22442.35482.84121.35
Capital Expenditures
-58.26-93.91-170.09-133.47-76.89-30.26
Free Cash Flow
345.86264.8452.14308.88405.9591.09
Free Cash Flow Growth
97.07%407.99%-83.12%-23.91%345.66%-20.84%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
32.47%32.16%30.38%29.58%28.50%34.98%
Operating Margin
6.26%6.52%6.98%8.04%8.00%3.17%
Pretax Margin
7.65%6.37%6.91%6.83%7.21%4.22%
Profit Margin
2.16%1.49%2.20%2.52%4.12%1.97%
FCF Margin
6.35%5.04%1.09%6.80%9.28%6.22%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
2.0002.0001.6502.0002.1000.500
Dividend Per Share Growth
21.21%21.21%-17.50%-4.76%320.00%-50.00%
Dividend Yield
4.53%4.54%3.50%3.13%3.28%1.51%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
16.8125.1420.0724.8915.8251.30
Forward PE
-32.8332.8332.8332.8332.83
P/FCF Ratio
5.707.4240.359.237.0316.24
PS Ratio
0.360.370.440.630.651.01